drugset / Trial / NCT01068600

Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks

NCT01068600

Phase 3 Completed 318 enrolled Novartis
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.

Timeline

Start
2010-01
Primary completion
2010-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Indacaterol Other / unclassified 75 ug Inhaled